(Press-News.org) A team of computer scientists and designers based out of the University of Waterloo have developed a tool to help people use colour better in graphic design.
The tool, De-Stijl, uses powerful machine learning technology to suggest intuitive colour palettes for novice designers and inexperienced users. The software combines and improves on the functionalities of existing tools like Figma, Pixlr, and Coolor, allowing users to select important theme colors and quickly visualize how they’ll impact a design.
“You put your graphical elements into the canvas,” said Jian Zhao, an assistant professor of computer science at Waterloo. “De-Stijl separates it into background, image, decoration and text, and based on these it creates a palette and then can make recommendations based on the design elements of layout, colour proximity, and proportion.”
De-Stijl’s most exciting contribution is an innovative 2-D colour palette, developed in consultation with expert graphic designers, that not only suggests colours but also demonstrates their impact in different distributions.
“Humans perceive colors differently based on their proportion and their placement,” said Xinyu Shi, a PhD student in computer science and the lead author on the research. “With the 2D format, users can better perceive how their current graphic designs look, focusing on the colour itself.”
The Waterloo-led project grew out of a longstanding relationship with Adobe, the design powerhouse responsible for products like Photoshop and InDesign.
Adobe realized that a lot of people responsible for creating branding and other marketing materials didn’t have advanced graphic design knowledge or the resources to hire expert designers. They tasked the Waterloo team with helping them find AI-powered solutions for these novice designers.
The De-Stijl team worked with a combination of design experts and ordinary users to build and test the software. During the testing phase, users customized marketing materials from provided templates using both De-Stijl and its competitors.
“No one tool can do the work that De-Stijl can do,” Zhao, said. “So we compared it to a suite of tools as a baseline.”
In anonymous expert assessments, De-Stijl outperformed the competition in usability, customization and attractiveness of design.
Shi emphasized that De-Stijl is not meant to replace expert graphic designers or human creativity. Rather, they want to remove some of the tedious guesswork from graphic design.
“Our aim is to facilitate, not replace,” Shi said.
The research paper, “De-Stijl: Facilitating Graphics Design with Interactive 2D Color Palette Recommendation,” was published in Proceedings of the 2023 CHI Conference on Human Factors in Computing Systems (CHI ’23), April 23-28, Hamburg, Germany.
END
Dreaming in technicolor
2023-07-20
ELSE PRESS RELEASES FROM THIS DATE:
NIH renews UC Davis MIND Institute grant to study fragile X-associated syndromes for 24th year
2023-07-20
It’s been 22 years since UC Davis MIND Institute Medical Director Randi Hagerman and her husband, researcher Paul Hagerman, discovered the neurodegenerative condition called FXTAS (fragile X-associated tremor ataxia syndrome). Hagerman, a pediatrician known for her enthusiasm for her work and patients, has been studying FXTAS ever since, seeking to develop treatments for it.
She was recently awarded her 24th consecutive year of funding from the National Institutes of Health for her fragile X-related work, a ...
AI must not worsen health inequalities for ethnic minority populations
2023-07-20
Scientists are urging caution before artificial intelligence (AI) models such as ChatGPT are used in healthcare for ethnic minority populations. Writing in the Journal of the Royal Society of Medicine, epidemiologists at the University of Leicester and University of Cambridge say that existing inequalities for ethnic minorities may become more entrenched due to systemic biases in the data used by healthcare AI tools.
AI models need to be ‘trained’ using data scraped from different sources such as healthcare websites and scientific research. However, evidence shows ...
Monitoring T cells may allow prevention of type 1 diabetes
2023-07-20
LA JOLLA, CA—Scripps Research scientists have shown that analyzing a certain type of immune cell in the blood can help identify people at risk of developing type 1 diabetes, a life-threatening autoimmune disease. The new approach, if validated in further studies, could be used to select suitable patients for treatment that stops the autoimmune process—making type 1 diabetes a preventable condition.
In the study, which appeared in Science Translational Medicine on July 5, 2023, the researchers ...
Important groups of phytoplankton tolerate some strategies to remove CO2 from the ocean
2023-07-20
Humanity has a long track record of making big changes with little forethought. From fossil fuels to AI, plastics to pesticides, we love innovating away our problems, only to find we’ve created different ones. So it can be refreshing to hear about cases where we’ve taken a step back to deliberate before committing to a drastic new idea, like carbon dioxide removal.
With carbon emissions continuing to climb, many scientists, environmentalists and policy-makers have advocated taking action to directly ...
Private equity takeovers of healthcare services linked to patient harm
2023-07-20
Private equity ownership of healthcare services such as nursing homes and hospitals is associated with harmful impacts on costs and quality of care, suggests a review of the latest evidence published by The BMJ today.
No consistently beneficial impacts of private equity ownership were identified, and the researchers say these results confirm the need for more research on private equity ownership in healthcare and possibly increased regulation.
Private equity firms use capital from wealthy individuals and large institutional investors to buy companies, and, after a relatively brief period of ownership, ...
Disrupted access to healthcare during pandemic linked to avoidable hospital admissions
2023-07-20
People who experienced disrupted access to healthcare (including appointments and procedures) during the covid-19 pandemic were more likely to have potentially preventable hospital admissions, finds a study published by The BMJ today.
This is the first study to examine the impact of disruption on health outcomes using individual level longitudinal data, and the researchers say reducing the backlog from covid-19 disruption is vital to tackle the short and long term implications of the pandemic.
The ...
Exposure to antiseizure medications does not harm neurological development in young children
2023-07-20
PITTSBURGH, July 19, 2023 — Most mothers who took prescription antiseizure medications during pregnancy can breathe a sigh of relief: A new study published today in Lancet Neurology found that young children who were exposed to commonly-prescribed medications in utero do not have worse neurodevelopmental outcomes than children of healthy women.
Commonly used antiseizure medications such as lamotrigine and levetiracetam are generally considered effective and safe, especially compared to many first-generation epilepsy treatments that carried profound risks to the unborn child. ...
AJR on sociodemographic factors and screening CTC among Medicare beneficiaries
2023-07-20
Leesburg, VA, July 19, 2023—According to an accepted manuscript published in the American Journal of Roentgenology (AJR), lacking Medicare coverage could contribute to greater income-based differences in use of screening CT colonography (CTC) than of other recommended screening strategies or of diagnostic CTC.
Noting that Medicare’s non-coverage for screening CTC may account for lower adherence with screening guidelines among lower-income beneficiaries, “Medicare coverage of CTC could reduce income-based disparities for individuals avoiding optical colonoscopy due to invasiveness, need for anesthesia, or complication ...
Study sheds light on cellular interactions that lead to liver transplant survival
2023-07-20
A new study identifies how certain proteins in the immune system interact leading to organ rejection. The study, which involved experiments on mice and human patients, uncovered an important communication pathway between two molecules called CEACAM1 (CC1) and TIM-3, finding that the pathway plays a crucial role in controlling the body's immune response during liver transplantation.
When an organ is transplanted from a donor to a recipient, the recipient's immune system recognizes the transplanted tissue as foreign, activating an immune response that can lead to rejection. T cells play a significant role ...
A potential new biomarker for Alzheimer’s
2023-07-20
Alzheimer’s is considered a disease of old age, with most people being diagnosed after 65. But the condition actually begins developing out of sight many years before any symptoms emerge. Tiny proteins, known as amyloid-beta peptides, clump together in the brain to form plaques. These plaques lead to inflammation and eventually cause neuronal cell death.
Interplay of proteins in the brain reveals disease mechanism
Exactly what triggers these pathological changes is still unclear. “We’re lacking good diagnostic markers that would allow us to reliably detect the disease at an early stage or make predictions about its course,” says Professor ...